Share Price and Basic Stock Data
Last Updated: December 9, 2025, 4:46 pm
| PEG Ratio | -2.31 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Jocil Ltd operates within the organic chemicals sector, a niche that has seen fluctuations in demand and pricing over recent quarters. The company reported sales of ₹919 Cr for FY 2023, up from ₹754 Cr the previous year, reflecting a growth trajectory. However, the latest quarterly figures reveal a more mixed performance. Sales dipped to ₹180.13 Cr in June 2023 but rebounded to ₹218.38 Cr by September 2023. This volatility, with quarterly sales ranging from ₹172.37 Cr to ₹284.41 Cr over the past year, suggests that Jocil is grappling with market dynamics that can impact its revenue consistency. A closer look at the trailing twelve months indicates total sales of ₹898 Cr, which positions the company as a smaller player in a competitive market. The revenue growth, while promising, requires sustained momentum to reassure stakeholders about its long-term viability.
Profitability and Efficiency Metrics
Profitability at Jocil Ltd has been a point of concern, with a reported net profit of just ₹1 Cr for FY 2025, a significant decline from ₹10 Cr in FY 2023. The operating profit margin (OPM) has also suffered, standing at a mere 1.39%, which is considerably lower than industry standards. This decline is further exemplified by negative operating profits in several quarters, such as a loss of ₹2.88 Cr in December 2023. The company’s return on equity (ROE) is currently at 0.48%, while the return on capital employed (ROCE) is slightly better at 0.71%. These figures indicate that Jocil is facing challenges in converting sales into profit effectively. The high interest coverage ratio of 31.18x reflects a strong ability to meet interest obligations, but it also highlights the disparity between earnings and profitability, pointing to a need for operational improvements.
Balance Sheet Strength and Financial Ratios
The balance sheet of Jocil Ltd appears relatively stable, with total borrowings recorded at just ₹5 Cr, indicating a low debt level compared to its equity base. This translates to a debt-to-equity ratio of 0.00, suggesting that the company is not heavily reliant on external financing. Reserves stand at ₹201 Cr, providing a cushion for future investments or operational challenges. However, the price-to-book value at 0.59x raises questions about market perceptions of the company’s intrinsic value. The current ratio of 2.99 indicates a comfortable liquidity position, although the negative trends in profitability could overshadow these strengths if not addressed. Investors should note that while the balance sheet appears robust, sustained profitability is essential for long-term stability and growth.
Shareholding Pattern and Investor Confidence
Investor confidence in Jocil Ltd reflects a cautious sentiment, with promoters holding a stable 55.02% stake, indicating a strong commitment from the founding team. However, foreign institutional investors (FIIs) have shown little interest, holding a mere 0.00% stake as of September 2023. This lack of external investment could be a red flag, suggesting that institutional investors are wary of the company’s recent performance. The public holding is at 44.98%, with a total of 7,446 shareholders, indicating a relatively dispersed ownership structure. The decline in the number of shareholders from 8,736 in December 2022 to the current figure highlights potential concerns among retail investors. As the company navigates through profitability issues, the stability of its shareholding pattern will be crucial in maintaining investor trust and attracting new capital.
Outlook, Risks, and Final Insight
The outlook for Jocil Ltd appears mixed, with significant risks overshadowing its operational strengths. The volatility in sales and profitability metrics raises concerns about the company’s ability to maintain steady growth, particularly in an industry characterized by fluctuating demand. Additionally, the absence of FIIs and declining shareholder numbers could signal underlying issues that may deter potential investors. On the flip side, the company’s low debt levels and stable promoter holding provide a solid foundation to build upon. Investors should consider the potential for recovery if operational efficiencies can be improved, yet remain vigilant regarding the risks tied to profitability and market perception. Ultimately, the key for Jocil will be to translate its revenue into sustainable profits while enhancing investor confidence through transparent communication and strategic initiatives.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Jocil Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 101 Cr. | 282 | 456/255 | 234 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,296 Cr. | 9,203 | 14,250/8,150 | 52.8 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 36.0 Cr. | 120 | 329/109 | 17.8 | 26.9 | 0.83 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 295 Cr. | 369 | 435/163 | 16.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,336.31 Cr | 1,539.72 | 65.11 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 284.41 | 241.96 | 192.81 | 200.10 | 180.13 | 218.38 | 172.37 | 182.32 | 237.70 | 229.74 | 219.95 | 178.15 | 269.94 |
| Expenses | 279.48 | 238.03 | 188.58 | 195.48 | 177.86 | 215.83 | 175.25 | 179.15 | 234.34 | 227.08 | 222.06 | 176.76 | 266.18 |
| Operating Profit | 4.93 | 3.93 | 4.23 | 4.62 | 2.27 | 2.55 | -2.88 | 3.17 | 3.36 | 2.66 | -2.11 | 1.39 | 3.76 |
| OPM % | 1.73% | 1.62% | 2.19% | 2.31% | 1.26% | 1.17% | -1.67% | 1.74% | 1.41% | 1.16% | -0.96% | 0.78% | 1.39% |
| Other Income | 0.12 | 1.03 | 0.54 | 0.69 | 0.91 | 1.40 | 0.56 | 1.10 | 0.77 | 0.40 | 0.10 | 0.68 | 0.49 |
| Interest | 0.42 | 0.30 | 0.24 | 0.18 | 0.01 | 0.00 | 0.27 | 0.05 | 0.00 | 0.10 | 0.07 | 0.06 | 0.06 |
| Depreciation | 1.57 | 1.52 | 1.55 | 1.56 | 1.38 | 1.48 | 1.63 | 1.62 | 1.39 | 1.42 | 1.43 | 1.42 | 1.22 |
| Profit before tax | 3.06 | 3.14 | 2.98 | 3.57 | 1.79 | 2.47 | -4.22 | 2.60 | 2.74 | 1.54 | -3.51 | 0.59 | 2.97 |
| Tax % | 25.16% | 25.16% | 24.83% | 12.32% | 25.14% | 25.51% | -25.12% | 35.00% | 25.18% | 25.32% | -25.36% | 22.03% | 25.25% |
| Net Profit | 2.29 | 2.35 | 2.23 | 3.13 | 1.34 | 1.85 | -3.16 | 1.69 | 2.05 | 1.15 | -2.63 | 0.45 | 2.22 |
| EPS in Rs | 2.58 | 2.65 | 2.51 | 3.52 | 1.51 | 2.08 | -3.56 | 1.90 | 2.31 | 1.29 | -2.96 | 0.51 | 2.50 |
Last Updated: August 20, 2025, 8:30 am
Below is a detailed analysis of the quarterly data for Jocil Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 269.94 Cr.. The value appears strong and on an upward trend. It has increased from 178.15 Cr. (Mar 2025) to 269.94 Cr., marking an increase of 91.79 Cr..
- For Expenses, as of Jun 2025, the value is 266.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.76 Cr. (Mar 2025) to 266.18 Cr., marking an increase of 89.42 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.76 Cr.. The value appears strong and on an upward trend. It has increased from 1.39 Cr. (Mar 2025) to 3.76 Cr., marking an increase of 2.37 Cr..
- For OPM %, as of Jun 2025, the value is 1.39%. The value appears strong and on an upward trend. It has increased from 0.78% (Mar 2025) to 1.39%, marking an increase of 0.61%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 0.68 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 0.19 Cr..
- For Interest, as of Jun 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For Depreciation, as of Jun 2025, the value is 1.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.42 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.20 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.97 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 2.97 Cr., marking an increase of 2.38 Cr..
- For Tax %, as of Jun 2025, the value is 25.25%. The value appears to be increasing, which may not be favorable. It has increased from 22.03% (Mar 2025) to 25.25%, marking an increase of 3.22%.
- For Net Profit, as of Jun 2025, the value is 2.22 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Mar 2025) to 2.22 Cr., marking an increase of 1.77 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.50. The value appears strong and on an upward trend. It has increased from 0.51 (Mar 2025) to 2.50, marking an increase of 1.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:03 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 375 | 331 | 393 | 376 | 341 | 402 | 446 | 565 | 754 | 919 | 753 | 866 | 898 |
| Expenses | 349 | 305 | 361 | 360 | 331 | 396 | 427 | 544 | 738 | 902 | 748 | 860 | 892 |
| Operating Profit | 26 | 25 | 32 | 16 | 11 | 7 | 19 | 21 | 15 | 18 | 5 | 5 | 6 |
| OPM % | 7% | 8% | 8% | 4% | 3% | 2% | 4% | 4% | 2% | 2% | 1% | 1% | 1% |
| Other Income | 2 | 2 | 5 | 3 | 2 | 2 | 6 | 1 | 1 | 2 | 4 | 2 | 2 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 10 | 7 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 5 |
| Profit before tax | 16 | 20 | 27 | 10 | 5 | 1 | 18 | 15 | 10 | 13 | 3 | 1 | 2 |
| Tax % | 30% | 33% | 34% | 19% | 17% | -152% | 29% | 12% | 26% | 22% | 35% | 24% | |
| Net Profit | 11 | 13 | 18 | 8 | 4 | 3 | 12 | 14 | 7 | 10 | 2 | 1 | 1 |
| EPS in Rs | 12.76 | 14.76 | 20.37 | 9.24 | 4.62 | 3.57 | 14.06 | 15.32 | 8.03 | 11.26 | 1.95 | 1.15 | 1.34 |
| Dividend Payout % | 39% | 41% | 34% | 32% | 43% | 28% | 21% | 20% | 25% | 22% | 77% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.18% | 38.46% | -55.56% | -50.00% | -25.00% | 300.00% | 16.67% | -50.00% | 42.86% | -80.00% | -50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.28% | -94.02% | 5.56% | 25.00% | 325.00% | -283.33% | -66.67% | 92.86% | -122.86% | 30.00% |
Jocil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -40% |
| 3 Years: | -48% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -3% |
| 3 Years: | -8% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 8:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:29 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 133 | 139 | 150 | 159 | 163 | 165 | 172 | 187 | 195 | 198 | 202 | 197 | 201 |
| Borrowings | 12 | 11 | 9 | 28 | 7 | 8 | 8 | 2 | 4 | 2 | 6 | 0 | 5 |
| Other Liabilities | 89 | 41 | 40 | 54 | 33 | 30 | 51 | 54 | 49 | 46 | 62 | 82 | 74 |
| Total Liabilities | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
| Fixed Assets | 74 | 67 | 63 | 59 | 54 | 50 | 48 | 48 | 47 | 44 | 41 | 37 | 35 |
| CWIP | 0 | 1 | 1 | 2 | 1 | 4 | 5 | 6 | 3 | 0 | 1 | 8 | 9 |
| Investments | 1 | 1 | 1 | 3 | 16 | 9 | 2 | 20 | 9 | 35 | 37 | 30 | 14 |
| Other Assets | 168 | 130 | 143 | 187 | 141 | 150 | 185 | 178 | 198 | 175 | 200 | 212 | 232 |
| Total Assets | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
Below is a detailed analysis of the balance sheet data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 16.00 Cr..
- For Other Assets, as of Sep 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (201.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.00 | 14.00 | 23.00 | -12.00 | 4.00 | -1.00 | 11.00 | 19.00 | 11.00 | 16.00 | -1.00 | 5.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 53 | 57 | 88 | 53 | 52 | 66 | 55 | 36 | 29 | 32 | 21 |
| Inventory Days | 84 | 89 | 75 | 73 | 81 | 71 | 85 | 66 | 58 | 66 | ||
| Days Payable | 28 | 16 | 21 | 43 | 20 | 15 | 38 | 29 | 29 | 33 | ||
| Cash Conversion Cycle | 100 | 126 | 111 | 119 | 114 | 108 | 114 | 91 | 36 | 29 | 61 | 54 |
| Working Capital Days | 66 | 84 | 88 | 92 | 94 | 89 | 87 | 74 | 69 | 49 | 52 | 45 |
| ROCE % | 11% | 13% | 17% | 7% | 3% | 1% | 10% | 9% | 5% | 7% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Diluted EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Cash EPS (Rs.) | 7.53 | 8.81 | 18.25 | 15.71 | 21.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Dividend / Share (Rs.) | 0.50 | 1.50 | 2.50 | 2.00 | 3.00 |
| Revenue From Operations / Share (Rs.) | 974.53 | 848.04 | 1035.04 | 848.48 | 636.56 |
| PBDIT / Share (Rs.) | 8.15 | 10.22 | 22.62 | 18.66 | 24.69 |
| PBIT / Share (Rs.) | 1.77 | 3.35 | 15.63 | 10.98 | 18.37 |
| PBT / Share (Rs.) | 1.51 | 2.98 | 14.35 | 10.78 | 17.37 |
| Net Profit / Share (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| PBDIT Margin (%) | 0.83 | 1.20 | 2.18 | 2.19 | 3.87 |
| PBIT Margin (%) | 0.18 | 0.39 | 1.50 | 1.29 | 2.88 |
| PBT Margin (%) | 0.15 | 0.35 | 1.38 | 1.27 | 2.72 |
| Net Profit Margin (%) | 0.11 | 0.22 | 1.08 | 0.94 | 2.40 |
| Return on Networth / Equity (%) | 0.49 | 0.82 | 4.84 | 3.49 | 6.93 |
| Return on Capital Employeed (%) | 0.75 | 1.39 | 6.60 | 4.69 | 8.12 |
| Return On Assets (%) | 0.35 | 0.61 | 3.94 | 2.77 | 5.39 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 3.06 | 2.83 | 3.60 | 2.96 | 2.30 |
| Current Ratio (X) | 2.99 | 3.48 | 4.64 | 3.93 | 3.67 |
| Quick Ratio (X) | 1.35 | 2.02 | 2.74 | 1.76 | 2.16 |
| Inventory Turnover Ratio (X) | 6.20 | 6.80 | 7.74 | 6.93 | 5.72 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 128.54 | 17.77 | 37.38 | 19.57 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 28.35 | 10.96 | 19.10 | 13.86 |
| Earning Retention Ratio (%) | 0.00 | -28.54 | 82.23 | 62.62 | 80.43 |
| Cash Earning Retention Ratio (%) | 0.00 | 71.65 | 89.04 | 80.90 | 86.14 |
| Interest Coverage Ratio (X) | 31.18 | 27.47 | 17.68 | 95.69 | 24.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.39 | 6.23 | 9.80 | 42.15 | 16.31 |
| Enterprise Value (Cr.) | 97.29 | 129.34 | 129.51 | 172.39 | 121.36 |
| EV / Net Operating Revenue (X) | 0.11 | 0.17 | 0.14 | 0.22 | 0.21 |
| EV / EBITDA (X) | 13.43 | 14.25 | 6.45 | 10.40 | 5.53 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| Retention Ratios (%) | 0.00 | -28.54 | 82.22 | 62.61 | 80.42 |
| Price / BV (X) | 0.59 | 0.71 | 0.65 | 0.84 | 0.65 |
| Price / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| EarningsYield | 0.01 | 0.01 | 0.07 | 0.04 | 0.10 |
After reviewing the key financial ratios for Jocil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.81 (Mar 24) to 7.53, marking a decrease of 1.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.50, marking a decrease of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.53. It has increased from 848.04 (Mar 24) to 974.53, marking an increase of 126.49.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 8.15, marking a decrease of 2.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 3.35 (Mar 24) to 1.77, marking a decrease of 1.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 1.51, marking a decrease of 1.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 2. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For PBDIT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.20 (Mar 24) to 0.83, marking a decrease of 0.37.
- For PBIT Margin (%), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 10. It has decreased from 0.39 (Mar 24) to 0.18, marking a decrease of 0.21.
- For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 0.35 (Mar 24) to 0.15, marking a decrease of 0.20.
- For Net Profit Margin (%), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 24) to 0.11, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 15. It has decreased from 0.82 (Mar 24) to 0.49, marking a decrease of 0.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 10. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
- For Return On Assets (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.35, marking a decrease of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 3.06. It has increased from 2.83 (Mar 24) to 3.06, marking an increase of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.99, marking a decrease of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.35, marking a decrease of 0.67.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.80 (Mar 24) to 6.20, marking a decrease of 0.60.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 128.54 (Mar 24) to 0.00, marking a decrease of 128.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.35 (Mar 24) to 0.00, marking a decrease of 28.35.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.65 (Mar 24) to 0.00, marking a decrease of 71.65.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 27.47 (Mar 24) to 31.18, marking an increase of 3.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 6.23 (Mar 24) to 5.39, marking a decrease of 0.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 97.29. It has decreased from 129.34 (Mar 24) to 97.29, marking a decrease of 32.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 13.43, marking a decrease of 0.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
- For Price / BV (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.59, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jocil Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.75% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.49% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 69.4 (Industry average Stock P/E: 65.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Dokiparru Village, Guntur District Andhra Pradesh 522438 | jocil@jocil.net http://www.jocil.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Narendranath Chowdary | Chairman |
| Mr. J Murali Mohan | Managing Director |
| Mr. Mullapudi Thimmaraja | Director |
| Mr. K Srinivasa Rao | Director |
| Mr. M Mrutyumjaya Prasad | Director |
| Mr. V S Raju | Independent Director |
| Dr. V N Rao | Independent Director |
| Mrs. Bhargavi Vangala | Independent Director |
| Mr. K Rama Seshayya | Independent Director |
| Mr. P A Chowdary | Independent Director |
| Mr. P Kesavulu Reddy | Independent Director |
| Mr. G S V Prasad | Independent Director |
FAQ
What is the intrinsic value of Jocil Ltd?
Jocil Ltd's intrinsic value (as of 10 December 2025) is 63.10 which is 57.65% lower the current market price of 149.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 133 Cr. market cap, FY2025-2026 high/low of 214/132, reserves of ₹201 Cr, and liabilities of 290 Cr.
What is the Market Cap of Jocil Ltd?
The Market Cap of Jocil Ltd is 133 Cr..
What is the current Stock Price of Jocil Ltd as on 10 December 2025?
The current stock price of Jocil Ltd as on 10 December 2025 is 149.
What is the High / Low of Jocil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jocil Ltd stocks is 214/132.
What is the Stock P/E of Jocil Ltd?
The Stock P/E of Jocil Ltd is 69.4.
What is the Book Value of Jocil Ltd?
The Book Value of Jocil Ltd is 236.
What is the Dividend Yield of Jocil Ltd?
The Dividend Yield of Jocil Ltd is 0.33 %.
What is the ROCE of Jocil Ltd?
The ROCE of Jocil Ltd is 0.71 %.
What is the ROE of Jocil Ltd?
The ROE of Jocil Ltd is 0.48 %.
What is the Face Value of Jocil Ltd?
The Face Value of Jocil Ltd is 10.0.